The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data.
Gabriel ChodickLilac TeneRan S RotemTal PatalonSivan GazitAmir Ben-TovClara WeilInbal GoldshteinGilad TwigDani CohenKhitam MuhsenPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
The effectiveness of the BNT162b2 vaccine is comparable to the one reported in the phase III clinical trial.